Testing effectiveness (Phase 2)Looking for participantsNCT07423533
What this trial is testing
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Who this might be right for
Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 450